Dr. Reddy's Laboratories Limited

DecreasedQuarterly

DRREDDYPharmaceuticalsMarket Cap₹98K Cr

Stake

11.94% → 11.41%

JPMorgan

Foreign Investor

The move

JPMorgan decreased its stake in Dr. Reddy's Laboratories Limited from 11.94% to 11.41%. While the exact number of shares and value for this transaction are not available, other sources indicate JPMorgan sold 130,856 shares in June 2020 for ₹11.2 crore.

About Dr. Reddy's Laboratories Limited

Visit stock

A leading India-based pharmaceutical company, Dr Reddy's Laboratories manufactures and distributes Active Pharmaceutical Ingredients, generic medicines, biosimilars, and differentiated formulations across multiple therapeutic areas. The company operates custom pharmaceutical services and serves patients in markets worldwide. Its integrated operations span drug discovery, development, manufacturing, and commercialization of innovative and generic pharmaceuticals for diverse healthcare needs.

About JPMorgan

Visit investor

US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.

Get the next move the moment it happens.

Follow JPMorgan and Dr. Reddy's Laboratories Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Dr. Reddy's Laboratories Limited shareholders JPMorgan's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Dr. Reddy's Laboratories Limited

ICICI Prudential Mutual FundIncreased

ICICI Prudential Mutual Fund raised its stake in Dr. Reddy's Laboratories from 4.92% to 5.01%, buying 7,12,884 shares in an open market transaction and crossing the 5% disclosure threshold.

12 Aug 2026

Nippon India Mutual FundDecreased

Nippon India Mutual Fund decreased its stake in Dr. Reddy's Laboratories by selling 3,705,462 shares. The fund's holding changed from 15,130,303 shares to 11,424,841 shares.